Evaluating vessel imaging for coronary artery disease
Official title: Vessel Imaging Using Optical Coherence Tomography for Plaque Morphology and Vessel Fractional Flow Reserve
Run by Medical University of Warsaw · NCT06844942 · Data updated 2026-11-12
This study is testing if a special imaging technique can help doctors better understand plaque in the arteries of people with heart issues and see how it relates to blood flow.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Medical University of Warsaw Academic / other |
| Locations | 1 site (Warsaw, Mazowieckie Voivodenship) |
| Status | Recruiting |
| Started | September 20, 2020 |
| Main results expected | December 31, 2027 |
| Study ends | January 31, 2029 |
| Registry record updated | February 25, 2025 |
| Trial ID | NCT06844942 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with chronic coronary syndrome and intermediate grade coronary stenosis.
✕Probably not a fit
Patients with acute coronary syndrome, severe heart failure, or other significant comorbidities may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess the diagnostic accuracy of optical coherence tomography (OCT) in evaluating plaque morphology and its correlation with vessel fractional flow reserve (vFFR) in patients with chronic coronary syndrome and intermediate grade coronary stenosis. It will analyze morphometric indices such as minimal lumen area and plaque type, including thin cap fibroatheroma. The study will also explore how factors like age, sex, diabetes, and renal dysfunction influence the relationship between vFFR and these morphometric parameters. Participants will undergo OCT and angiography to gather data for this analysis.
Why it matters
Potential benefit: If successful, this study could improve the diagnostic accuracy for assessing coronary artery disease and guide treatment decisions.
How similar studies have gone: Similar studies using optical coherence tomography for coronary assessments have shown promising results, indicating potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years or older * Chronic coronary syndrome defined as presence of chest pain ranked 2-3 in the Canadian Cardiovascular Society classification or positive ischemia test (exercise test, single photon emission tomography (SPECT) * Intermediate grade coronary stenosis of 40-80% assessed visually in coronary angiography and OCT examination The patient is willing to participate in the study and has provided a written informed consent Exclusion Criteria: * Acute coronary syndrome * Proximal left main lesion * Ostial right coronary artery lesion * Bypass of the assessed vessel * Contraindications for adenosine administration * Hemodynamic instability * Heart insufficiency in New York Heart Association (NYHA) class IV scale * Acute renal insufficiency * Pregnancy
Where it's running
-
1st Department and Clinic of Cardiology, Medical University of Warsaw
Warsaw, Mazowieckie Voivodenship, Poland Recruiting
Study contacts
- Study coordinator: Mariusz Tomaniak, MD, PhD, Assoc. Prof.
- Email: mariusz.tomaniak@wum.edu.pl
- Phone: 0048225991958
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Clinical features, treatments, and outcomes in inflammation-associated non-rapidly-progressive coronary artery disease
This study will see how current treatments, inflammation markers, and patient characteristics relate to outcomes in people with inflammation-associated non-rapidly-progressive coronary artery disease (INR-CAD).
-
IRIS Coroflex NEO stent registry
This project tests whether Coroflex ISAR NEO drug-eluting stents are safe and work well for adults having percutaneous coronary intervention for coronary artery disease.
-
Investigating characteristics of a special type of coronary artery disease
This study is trying to understand the unique features of a fast-progressing type of coronary artery disease by comparing patients with this condition to those with a more common form of the disease.
-
Evaluating comprehensive treatment for rapidly-progressive coronary artery disease
This study is testing a new treatment plan for people with rapidly-progressive coronary artery disease that includes medication and procedures to see if it helps them feel better and manage their condition.
-
μFR-guided Drug-Coated Balloon Angioplasty vs Angiography-guided Angioplasty in Coronary Artery Disease
This trial tests whether using computational μFR guidance during drug-coated balloon angioplasty is better than standard angiography guidance for people with de novo coronary artery lesions.
-
Gastric Ultrasound Before CABG to See if Heart Function Changes Stomach Contents
This study checks whether people with weaker heart function before elective CABG have different stomach contents seen on ultrasound.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.